1. Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis. (September 2019) Authors: Ryan, P; McBride, A; Ray, D; Pulgar, S; Ramirez, RA; Elquza, E; Favaro, JP; Dranitsaris, G Journal: Journal of oncology pharmacy practice Issue: Volume 25:Number 6(2019) Page Start: 1425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗